Montelukast not linked to increased risk of ADHD in kids with Asthma: Study
Written By : Dr. Nandita Mohan
Medically Reviewed By : Dr. Kamal Kant Kohli
Published On 2020-12-07 02:45 GMT | Update On 2023-10-18 11:50 GMT

Advertisement
According to a nationwide population-based cohort study, researchers have revealed that asthma children treated with montelukast were not at an increased risk of developing ADHD, as published in the Journal of the Formosan Medical Association.
Attention-deficit/hyperactivity disorder (ADHD) has been linked to pediatric asthma patients treated with montelukast. A recent case-control study has reconsidered the benefit/risk ratio in child patients with asthma when considering montelukast, with close monitoring indicating that the neuropsychiatric adverse drug reactions have nearly double the risk compared with controls.
However, the mechanisms of the neuropsychiatric events of montelukast, including ADHD, are currently not clear. Although montelukast is a safe drug, these symptoms must be monitored, especially in children.
Hence, Po-Yu Huang and colleagues from the Department of Traditional Chinese Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan conducted this nationwide, population-based study with the sole aim to examine the risk of developing ADHD among asthma patients treated with montelukast in the 0- to the 12-year-old pediatric group.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.